Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2021 08:01 ET | Source: Kapitalforeningen Lån & Spar MixInvest

Årsrapport 2020

Bestyrelsen for Kapitalforeningen Lån & Spar MixInvest har den 24. februar 2021 afholdt bestyrelsesmøde, hvor bestyrelsen besluttede at indstille årsrapport 2020 til godkendelse på foreningens...
February 24, 2021 08:00 ET | Source: Xebec Adsorption

Xebec Announces $59M in Credit Facilities from National Bank of Canada

MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of clean energy solutions for renewable and low carbon gases, announced today that it has...
February 24, 2021 08:00 ET | Source: Macarthur Minerals Limited

Macarthur Minerals Enters Into Exclusive Agreement Over 10 Historic Prospecting and Mining Lease Tenements in the Central Goldfields of Western Australia

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Macarthur Minerals Limited (TSX-V: MMS) (ASX: MIO) (OTCQB: MMSDF) (the “Company” or “Macarthur”) is pleased to advise shareholders that...
February 24, 2021 08:00 ET | Source: PIMCO Account Management

PIMCO Names Kimberley Stafford as Global Head of Product Strategy Group and Alec Kersman as Head of Asia-Pacific

Ms. Stafford, who is a member of PIMCO’s Executive Committee, will also serve as a Trustee on the Board of PIMCO FundsThe firm also names David Fisher, Eric Sutherland and Ryan Korinke, all Managing...
February 24, 2021 08:00 ET | Source: Exela Technologies, Inc.

Exela Technologies, Inc. to Participate in a Fireside Chat Hosted by Cowen

IRVING, Texas, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a global business process automation (BPA) leader, announced today that the...
February 24, 2021 08:00 ET | Source: Fortress Biotech, Inc.

Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement for Cyprium Therapeutics’ Copper Histidinate Product Candidate for Treatment of Menkes Disease

Sentynl acquires CUTX-101, Copper Histidinate, for $20 million in upfront and regulatory milestone payments through NDA approval, as well as potential sales milestones plus royalties Cyprium will...
February 24, 2021 08:00 ET | Source: Redwood Software

Redwood Software Names New CMO to Help Lead Growth in Automation Market

Frisco, TX, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Redwood Software, the leading cloud-based process automation provider, today announced the appointment of Amede Hungerford as its chief marketing...
February 24, 2021 08:00 ET | Source: Pacific Biosciences of California, Inc.

Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

KANSAS CITY, Mo. and MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms,...
February 24, 2021 08:00 ET | Source: Landmark Infrastructure Partners LP

Landmark Infrastructure Partners LP Reports Fourth Quarter and Full Year Results

EL SEGUNDO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Landmark Infrastructure Partners LP (“Landmark,” the “Partnership,” “we,” “us” or “our”) (Nasdaq: LMRK) today announced its fourth quarter...
February 24, 2021 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Reports Granting of New Employment Inducement Awards

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of...

1 ...112882 112883 112884 ...326068